Karen Joy Shaw - Search Results

Year	Number of Results
2003	3
2004	2
2005	1
2007	3
2008	2
2009	2
2010	2
2011	2
2012	1
2014	3
2018	2
2019	4
2020	4
2021	3
2022	3
2024	0

1

Fosmanogepix: A Review of the First-in-Class Broad Spectrum Agent for the Treatment of Invasive Fungal Infections.

Shaw KJ, Ibrahim AS. Shaw KJ, et al. J Fungi (Basel). 2020 Oct 22;6(4):239. doi: 10.3390/jof6040239. J Fungi (Basel). 2020. PMID: 33105672 Free PMC article. Review.

2

The oxazolidinones: past, present, and future.

Shaw KJ, Barbachyn MR. Shaw KJ, et al. Ann N Y Acad Sci. 2011 Dec;1241:48-70. doi: 10.1111/j.1749-6632.2011.06330.x. Ann N Y Acad Sci. 2011. PMID: 22191526 Review.

3

Transcriptional profiling and drug discovery.

Shaw KJ, Morrow BJ. Shaw KJ, et al. Curr Opin Pharmacol. 2003 Oct;3(5):508-12. doi: 10.1016/s1471-4892(03)00110-3. Curr Opin Pharmacol. 2003. PMID: 14559096 Review.

4

Tedizolid for the management of human infections: in vitro characteristics.

Locke JB, Zurenko GE, Shaw KJ, Bartizal K. Locke JB, et al. Among authors: shaw kj. Clin Infect Dis. 2014 Jan;58 Suppl 1:S35-42. doi: 10.1093/cid/cit616. Clin Infect Dis. 2014. PMID: 24343830 Review.

5

GR-2397: Review of the Novel Siderophore-like Antifungal Agent for the Treatment of Invasive Aspergillosis.

Shaw KJ. Shaw KJ. J Fungi (Basel). 2022 Aug 27;8(9):909. doi: 10.3390/jof8090909. J Fungi (Basel). 2022. PMID: 36135634 Free PMC article. Review.

6

Efficacy of APX2039 in a Rabbit Model of Cryptococcal Meningitis.

Giamberardino CD, Schell WA, Tenor JL, Toffaletti DL, Palmucci JR, Marius C, Boua JK, Soltow Q, Mansbach R, Moseley MA, Thompson JW, Dubois LG, Hope W, Perfect JR, Shaw KJ. Giamberardino CD, et al. Among authors: shaw kj. mBio. 2022 Dec 20;13(6):e0234722. doi: 10.1128/mbio.02347-22. Epub 2022 Oct 12. mBio. 2022. PMID: 36222509 Free PMC article.

7

In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus.

Shaw KJ, Schell WA, Covel J, Duboc G, Giamberardino C, Kapoor M, Moloney M, Soltow QA, Tenor JL, Toffaletti DL, Trzoss M, Webb P, Perfect JR. Shaw KJ, et al. Antimicrob Agents Chemother. 2018 Jul 27;62(8):e00523-18. doi: 10.1128/AAC.00523-18. Print 2018 Aug. Antimicrob Agents Chemother. 2018. PMID: 29891599 Free PMC article.

8

Enhanced Efflux Pump Expression in Candida Mutants Results in Decreased Manogepix Susceptibility.

Liston SD, Whitesell L, Kapoor M, Shaw KJ, Cowen LE. Liston SD, et al. Among authors: shaw kj. Antimicrob Agents Chemother. 2020 Apr 21;64(5):e00261-20. doi: 10.1128/AAC.00261-20. Print 2020 Apr 21. Antimicrob Agents Chemother. 2020. PMID: 32179530 Free PMC article.

9

Anthracimycin activity against contemporary methicillin-resistant Staphylococcus aureus.

Hensler ME, Jang KH, Thienphrapa W, Vuong L, Tran DN, Soubih E, Lin L, Haste NM, Cunningham ML, Kwan BP, Shaw KJ, Fenical W, Nizet V. Hensler ME, et al. Among authors: shaw kj. J Antibiot (Tokyo). 2014 Aug;67(8):549-53. doi: 10.1038/ja.2014.36. Epub 2014 Apr 16. J Antibiot (Tokyo). 2014. PMID: 24736856 Free PMC article.

10

The Combination Treatment of Fosmanogepix and Liposomal Amphotericin B Is Superior to Monotherapy in Treating Experimental Invasive Mold Infections.

Gebremariam T, Gu Y, Alkhazraji S, Youssef E, Shaw KJ, Ibrahim AS. Gebremariam T, et al. Among authors: shaw kj. Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0038022. doi: 10.1128/aac.00380-22. Epub 2022 Jun 7. Antimicrob Agents Chemother. 2022. PMID: 35670592 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

36 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year